AUROBINDO PHARMA Current Financial Leverage

AUROBINDO PHARMA's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. AUROBINDO PHARMA's financial risk is the risk to AUROBINDO PHARMA stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Check out Trending Equities.

AUROBINDO Bonds 

 
Refresh

AUROBINDO PHARMA Financial Leverage Rating

AUROBINDO PHARMA bond ratings play a critical role in determining how much AUROBINDO PHARMA have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for AUROBINDO PHARMA's borrowing costs.
Overall Bond Rating
Not Rated
Average S&P Rating
N/A

AUROBINDO PHARMA Debt to Cash Allocation

As AUROBINDO PHARMA follows its natural business cycle, the capital allocation decisions will not magically go away. AUROBINDO PHARMA's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors. Many companies eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has accumulated 67.53 B in total debt with debt to equity ratio (D/E) of 48.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AUROBINDO PHARMA has a current ratio of 1.25, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

AUROBINDO PHARMA Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the AUROBINDO PHARMA's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of AUROBINDO PHARMA, which in turn will lower the firm's financial flexibility. Like all other financial ratios, a an AUROBINDO PHARMA debt ratio should be compared their industry average or other competing firms.

AUROBINDO PHARMA Investors Sentiment

The influence of AUROBINDO PHARMA's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in AUROBINDO. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AUROBINDO PHARMA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AUROBINDO PHARMA's short interest history, or implied volatility extrapolated from AUROBINDO PHARMA options trading.

Current Sentiment - AUROPHARMA

AUROBINDO PHARMA Investor Sentiment

Most of Macroaxis users are presently bullish on AUROBINDO PHARMA. What is your sentiment towards investing in AUROBINDO PHARMA? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with AUROBINDO PHARMA

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AUROBINDO PHARMA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AUROBINDO PHARMA will appreciate offsetting losses from the drop in the long position's value.

AUROBINDO PHARMA Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for PNC Bank and Stifel Financial Corp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check out Trending Equities. Note that the AUROBINDO PHARMA information on this page should be used as a complementary analysis to other AUROBINDO PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Tools for AUROBINDO Stock

When running AUROBINDO PHARMA price analysis, check to measure AUROBINDO PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AUROBINDO PHARMA is operating at the current time. Most of AUROBINDO PHARMA's value examination focuses on studying past and present price action to predict the probability of AUROBINDO PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AUROBINDO PHARMA's price. Additionally, you may evaluate how the addition of AUROBINDO PHARMA to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.